Characteristics | BMI < 24(Group A) (N = 268) | BMI ≥ 24(Group B) (N = 187) | P value |
---|---|---|---|
Age(years) | 43.3(15.7) | 46.3(13.3) | 0.028 |
Sex |  |  | < 0.001 |
 men | 97(36.2%) | 119(63.6%) |  |
 women | 171(63.8%) | 68(36.4%) |  |
BMI (kg/m2) | 21.62(20.20–22.86) | 26.12(24.69–27.92) | < 0.001 |
Exposure history | |||
 Exposure to Wuhan | 122(45.5%) | 84(44.9%) | 0.899 |
 Contact with confirmed or suspected patients | 130(48.5%) | 76(40.6%) | 0.097 |
 Familial cluster | 93(34.7%) | 61(32.6%) | 0.644 |
Current smoking | 14(5.2%) | 20(10.7%) | 0.029 |
Condition | |||
 Any | 67(25.0%) | 82(43.9%) | < 0.001 |
 Hypertension | 26(9.7%) | 48(25.7%) | < 0.001 |
 Diabetes | 19(7.1%) | 21(11.2%) | 0.125 |
 Heart disease | 5(1.9%) | 5(2.7%) | 0.563 |
 Chronic liver disease | 8(3.0%) | 14(7.5%) | 0.028 |
 Chronic renal disease | 1(0.4%) | 2(1.1%) | 0.753 |
 Cancer | 3(1.1%) | 3(1.6%) | 0.977 |
 COPD | 0(0.0%) | 1(0.5%) | 0.411 |
 Immunosuppression | 0(0.0%) | 1(0.5%) | 0.411 |
Signs and symptoms | |||
 Fever | 213(79.5%) | 164(87.7%) | 0.022 |
 Highest temperature(°C) |  |  | 0.085 |
   < 37.3 | 55(20.5%) | 23(12.3%) |  |
  37.3–38.0 | 92(34.3%) | 80(42.8%) |  |
  38.1–39.0 | 101(37.7%) | 72(38.5%) |  |
   > 39.0 | 20(7.5%) | 12(6.4%) |  |
 Cough | 165(61.6%) | 136(72.7%) | 0.013 |
 Sputum production | 87(32.5%) | 79(42.2%) | 0.033 |
 Sore throat | 48(17.9%) | 20(10.7%) | 0.034 |
 Nasal obstruction | 20(7.5%) | 5(2.7%) | 0.027 |
 Myalgia | 32(11.9%) | 20(10.7%) | 0.681 |
 Fatigue | 58(21.6%) | 35(18.7%) | 0.787 |
 GI symptomsa | 36(13.4%) | 30(16.0%) | 0.437 |
 Headache | 20(7.5%) | 23(12.3%) | 0.083 |
Incubation period (days) | 7(4–11) (n = 86) | 7(4–10) (n = 46) | 0.578 |
Days from illness onset to first medical visit(days) | 2(1–5) | 3(1–5) | 0.143 |
Days from illness onset to confirm the diagnosis(days) | 5(3–8) | 5(3–8) | 0.393 |
Days from illness onset to first hospitalization(days) | 4(2–7) | 4(3–8) | 0.491 |
Clinical Type | Â | Â | 0.004 |
 Mild/ Moderate | 249(92.9%) | 158(84.5%) |  |
 Severe/ Critical | 19(7.1%) | 29(15.5%) |  |